These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The changing face of tuberculosis care in Russia. Balakrishnan VS Lancet Respir Med; 2018 Apr; 6(4):249-250. PubMed ID: 29595506 [No Abstract] [Full Text] [Related]
24. Multidrug-resistant tuberculosis on Australia's northern border. Simpson G Intern Med J; 2011 Nov; 41(11):759-61. PubMed ID: 22077943 [No Abstract] [Full Text] [Related]
25. Multi-drug-resistant central nervous system tuberculosis. Murthy JM Neurol India; 2012; 60(2):143-5. PubMed ID: 22626692 [No Abstract] [Full Text] [Related]
27. Prison health in Russia: the larger picture. Bobrik A; Danishevski K; Eroshina K; McKee M J Public Health Policy; 2005 Apr; 26(1):30-59. PubMed ID: 15906874 [TBL] [Abstract][Full Text] [Related]
28. Pilot study on multidrug resistant tuberculosis in Nigeria. Lawson L; Habib AG; Okobi MI; Idiong D; Olajide I; Emenyonu N; Onuoha N; Cuevas LE; Ogiri SO Ann Afr Med; 2010; 9(3):184-7. PubMed ID: 20710112 [TBL] [Abstract][Full Text] [Related]
29. Multidrug-resistant tuberculosis in Ukraine at a time of military conflict. Dudnyk A; Rzhepishevska O; Rogach K; Kutsyna G; Lange C Int J Tuberc Lung Dis; 2015 Apr; 19(4):492-3. PubMed ID: 25860008 [No Abstract] [Full Text] [Related]
30. Changing the game for multidrug-resistant tuberculosis. Ghanashyam B Lancet; 2016 Mar; 387(10024):1149-50. PubMed ID: 27025324 [No Abstract] [Full Text] [Related]
31. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'. Chiang CY; Caminero JA; Enarson DA Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184 [No Abstract] [Full Text] [Related]
32. TB surveillance in correctional institutions in Hong Kong, 1999-2005. Wong MY; Leung CC; Tam CM; Kam KM; Ma CH; Au KF Int J Tuberc Lung Dis; 2008 Jan; 12(1):93-8. PubMed ID: 18173884 [TBL] [Abstract][Full Text] [Related]
33. Totally drug-resistant tuberculosis in India: who let the djinn out? Udwadia ZF Respirology; 2012 Jul; 17(5):741-2. PubMed ID: 22564108 [No Abstract] [Full Text] [Related]
35. Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB? Edginton ME; Miller DL; Burney P; El Sony AI; Lwilla FI; O'Brien R; Roldan MB; Roldan A; Srinath S Int J Tuberc Lung Dis; 2010 Sep; 14(9):1094-6. PubMed ID: 20819252 [TBL] [Abstract][Full Text] [Related]
37. From the Centers for Disease Control and Prevention. Tuberculosis treatment interruptions--Ivanovo Oblast, Russian Federation, 1999. JAMA; 2001 Apr; 285(15):1953-4. PubMed ID: 11336045 [No Abstract] [Full Text] [Related]
38. Managing drug-resistant tuberculosis: experiences from India. Katoch VM Expert Rev Anti Infect Ther; 2010 May; 8(5):493-6. PubMed ID: 20455676 [No Abstract] [Full Text] [Related]
39. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571 [TBL] [Abstract][Full Text] [Related]
40. [Drug-resistant tuberculosis in the Republic of Karelia]. Markelov IuM; Dorodnaia IA Probl Tuberk Bolezn Legk; 2007; (8):8-10. PubMed ID: 17915460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]